By Brazil Stock Guide – Brazilian medical and hospital health-plan operators posted net income of R$4.89 billion in the second quarter of 2026, as financial income became an increasingly important source of earnings and comfortably exceeded the result generated by the core health-plan business.
Between April and June, the sector’s financial result reached R$3.94 billion, compared with an operating result of R$2.25 billion. Financial income was therefore about 75% higher than the operating result and accounted for nearly 58% of the R$6.80 billion in pre-tax and pre-participation earnings. The sector also recorded R$615 million in equity-related gains.
The shift in the earnings mix was one of the main points highlighted by Brazil’s National Supplementary Health Agency, or ANS, the regulator of the private health-plan industry. In the first quarter, operating and financial results had been much closer. In the second quarter, financial income accelerated and moved clearly ahead.
“The financial result got a real boost,” said Washington Alves, head of Licensing and Market Studies at ANS. “We are now seeing financial income at a level that is even higher than the operating result.”
The core health-plan business also remained profitable. The R$2.25 billion operating result in the second quarter was about 20% higher than in the same period of 2025. That helps distinguish the quarterly picture from the first-half numbers, which are still affected by an extraordinary R$2.7 billion technical provision booked by SulAmérica in the first quarter.
According to ANS, that non-recurring item distorts the year-on-year comparison for the accumulated operating result and should not be read as an equivalent deterioration in the underlying performance of the sector as a whole.
The improvement was also visible across the industry. About 71.4% of medical and hospital plan operators posted a net profit in the second quarter, up from 70.1% a year earlier. That is well above the 50.8% recorded in the second quarter of 2022, during one of the most difficult stages of the sector’s post-pandemic recovery.
The stronger financial contribution comes against a backdrop of high interest rates and a growing pool of invested assets. Medical and hospital plan operators ended June with about R$142.4 billion in financial investments, up from roughly R$140 billion in March and R$134 billion at the end of 2025.
The portfolio is overwhelmingly concentrated in fixed income. About R$87.7 billion, or 61.6%, was invested in private fixed-income instruments, while another R$51.6 billion, or 36.3%, was held in government securities. Roughly half of the portfolio was classified as guarantee assets backing technical provisions, while the remainder consisted of unrestricted investments.
ANS notes that financial income is a natural part of the health-plan business model. Operators collect premiums before a significant portion of healthcare expenses are paid, allowing them to invest those funds until claims and other obligations come due. High interest rates, however, have materially increased the returns generated by those portfolios.
Alves said the financial result is at record levels across virtually all types of operators, with the exception of self-managed plans, and that the impact is particularly strong among the largest companies, which hold the biggest investment portfolios.
“It is natural to have a culture of financial investment,” Alves said, referring to the timing gap between premium collection and the payment of healthcare expenses.
Bradesco leads the quarter
Among individual companies, Bradesco Saúde posted the highest net income in the second quarter, at R$911.3 million, equivalent to 18.6% of the total profit generated by medical and hospital plan operators during the period.
SulAmérica ranked second, with R$873.0 million, followed by Postal Saúde, at R$470.9 million, and Amil, at R$441.2 million. Together, the four companies accounted for roughly 55% of the sector’s quarterly net income.
The composition of earnings varied significantly across operators. At Bradesco Saúde, the R$873.4 million financial result was more than twice the R$425.0 million operating result.
At SulAmérica, the two components were almost evenly matched: R$454.7 million in operating profit and R$454.7 million in financial income. The insurer also booked R$300.1 million in equity-related gains, taking pre-tax earnings to R$1.21 billion.
Postal Saúde showed a very different earnings profile. Its R$470.9 million net profit came almost entirely from operations, which generated R$474.8 million in the quarter, while the financial result was slightly negative.
At Amil, the operating result reached R$356.9 million, while financial income totaled R$259.4 million, partly offset by a R$51.6 million negative equity-related result.
The next-largest profits came from Unimed Belo Horizonte, at R$239.8 million; Samedil, at R$186.0 million; Unimed Seguros Saúde, at R$180.8 million; and Porto Seguro Saúde, at R$145.7 million.
Among two of the main regulated operators within the Hapvida group, Notre Dame Intermédica posted net income of R$137.0 million in the second quarter, while Hapvida Assistência Médica earned R$49.5 million. Combined, the two ANS-regulated entities generated R$186.5 million in net income during the period.
The second-quarter numbers therefore point to two forces working at the same time. The core health-plan business remains profitable and improved from a year earlier, while high interest rates have turned operators’ investment portfolios into an even larger source of earnings. In Q2, the sector made money from healthcare — and even more from the cash it had invested.
Leave a Reply